Hamilton Lane (NASDAQ:HLNE – Get Free Report) was upgraded by stock analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage presently has a $186.00 target price on the stock. Oppenheimer’s price objective suggests a potential upside of 16.15% from the company’s current price.
HLNE has been the subject of a number of other research reports. UBS Group upped their price objective on Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 22nd. The Goldman Sachs Group downgraded shares of Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 price target on the stock. in a report on Monday, January 6th. JPMorgan Chase & Co. increased their price objective on shares of Hamilton Lane from $134.00 to $175.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Keefe, Bruyette & Woods dropped their price objective on shares of Hamilton Lane from $167.00 to $158.00 and set a “market perform” rating for the company in a research note on Monday, January 13th. Finally, Wells Fargo & Company dropped their target price on Hamilton Lane from $194.00 to $163.00 and set an “equal weight” rating for the company in a report on Tuesday, January 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Hamilton Lane has a consensus rating of “Hold” and a consensus price target of $170.86.
Check Out Our Latest Stock Report on HLNE
Hamilton Lane Price Performance
Hamilton Lane (NASDAQ:HLNE – Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.06 by $0.01. The business had revenue of $150.00 million for the quarter, compared to the consensus estimate of $151.55 million. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. The company’s revenue was up 18.2% compared to the same quarter last year. During the same period last year, the business posted $0.89 EPS. Research analysts expect that Hamilton Lane will post 4.88 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. FMR LLC grew its holdings in Hamilton Lane by 239.9% in the 3rd quarter. FMR LLC now owns 5,557 shares of the company’s stock valued at $936,000 after buying an additional 3,922 shares in the last quarter. Retirement Systems of Alabama acquired a new position in shares of Hamilton Lane during the 3rd quarter valued at about $8,291,000. Icon Wealth Advisors LLC purchased a new stake in shares of Hamilton Lane in the third quarter valued at about $819,000. Royce & Associates LP acquired a new stake in Hamilton Lane during the third quarter worth about $538,000. Finally, Teachers Retirement System of The State of Kentucky raised its stake in Hamilton Lane by 41.9% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 20,914 shares of the company’s stock worth $3,522,000 after purchasing an additional 6,178 shares during the period. Hedge funds and other institutional investors own 97.40% of the company’s stock.
About Hamilton Lane
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
See Also
- Five stocks we like better than Hamilton Lane
- What is the NASDAQ Stock Exchange?
- Oracle Announces Game-Changing News for the AI Industry
- Earnings Per Share Calculator: How to Calculate EPS
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is the Nikkei 225 index?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.